TrovaGene, Inc. Warrant
TROVW
TROVW was delisted on the 30th of May, 2017.
3 hedge funds and large institutions have $2.94M invested in TrovaGene, Inc. Warrant in 2015 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 2 reducing their positions, and 1 closing their positions.
13,482% more call options, than puts
Call options by funds: $1.49M | Put options by funds: $11K
25% less funds holding
Funds holding: 4 → 3 (-1)
26% less capital invested
Capital invested by funds: $3.98M → $2.94M (-$1.04M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$16.2K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$1K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$73 |
TROVW Hedge Fund Activity: Q3 2015 in Review
3 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in TrovaGene, Inc. Warrant (TROVW) for Q3 2015, worth a combined $2.94M — down 26% from $3.98M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of TROVW and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 0 added.
The largest seller was Millennium Management, cutting an estimated $16.2K.
- 3 institutional investors held TrovaGene, Inc. Warrant (TROVW) as of Q3 2015, down from 4 in Q2 2015.
- Funds reported $2.94M of TrovaGene, Inc. Warrant stock for Q3 2015, down 26% quarter-over-quarter.
- 0 funds opened new TrovaGene, Inc. Warrant positions in Q3 2015 and 1 closed out, a net change of -1 holder.
- The largest TrovaGene, Inc. Warrant seller in Q3 2015 was Millennium Management, an estimated $16.2K sold.
Based on aggregated 13F filings for Q3 2015.